Matches in Wikidata for { <http://www.wikidata.org/entity/Q66034092> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q66034092 description "clinical trial" @default.
- Q66034092 description "ensayu clínicu" @default.
- Q66034092 description "klinisch onderzoek" @default.
- Q66034092 description "клінічне випробування" @default.
- Q66034092 description "կլինիկական փորձարկում" @default.
- Q66034092 name "Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis" @default.
- Q66034092 name "Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis" @default.
- Q66034092 type Item @default.
- Q66034092 label "Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis" @default.
- Q66034092 label "Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis" @default.
- Q66034092 prefLabel "Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis" @default.
- Q66034092 prefLabel "Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis" @default.
- Q66034092 P1050 Q66034092-C45AE562-BE3C-43DA-99E2-30B7660A023A @default.
- Q66034092 P1132 Q66034092-0A5F1DDC-F381-4701-956D-4AC27D785982 @default.
- Q66034092 P131 Q66034092-486A5705-9B09-4E53-ACD0-C307001F48EB @default.
- Q66034092 P1476 Q66034092-30628FAD-2219-483A-8B82-E375C1161654 @default.
- Q66034092 P17 Q66034092-A2BED006-A3FD-4A27-BBAE-878DC226A12D @default.
- Q66034092 P17 Q66034092-CA2453FE-11C3-4B23-8571-69E01C259A0F @default.
- Q66034092 P2899 Q66034092-79C90414-5370-429F-A0C8-34497A9165F7 @default.
- Q66034092 P3098 Q66034092-B670EF96-540A-4346-80AD-213CDA88F18A @default.
- Q66034092 P31 Q66034092-D7266AFF-F20A-46A3-8DA1-6A22247C9648 @default.
- Q66034092 P4135 Q66034092-3054E5B3-6FA5-4EAB-A39E-F06AB071C688 @default.
- Q66034092 P580 Q66034092-54D21786-295A-47C0-9F23-2873AEE95511 @default.
- Q66034092 P582 Q66034092-0F78D698-C88F-4B9A-A285-CCF12CCAA848 @default.
- Q66034092 P6099 Q66034092-935CD514-4732-43A8-96C4-0E41D77D6BBE @default.
- Q66034092 P6153 Q66034092-641ED4D6-60EB-4B32-B1B4-EC2F5C457B04 @default.
- Q66034092 P8363 Q66034092-6424F49C-D113-4F00-A4F0-3A99156D9927 @default.
- Q66034092 P1050 Q2453464 @default.
- Q66034092 P1132 "+386" @default.
- Q66034092 P131 Q1183 @default.
- Q66034092 P1476 "A Double-Blind, Randomized, 6-Week, Parallel-Group Design Clinical Trial to Assess Safety and Efficacy of Asacol 4.8 g/Day (800 mg Tablet) Versus Asacol 2.4 g/Day (400 mg Tablet) for the Treatment of Moderately Active Ulcerative Colitis" @default.
- Q66034092 P17 Q16 @default.
- Q66034092 P17 Q30 @default.
- Q66034092 P2899 "+18" @default.
- Q66034092 P3098 "NCT00073021" @default.
- Q66034092 P31 Q30612 @default.
- Q66034092 P4135 "+75" @default.
- Q66034092 P580 "2000-09-01T00:00:00Z" @default.
- Q66034092 P582 "2003-09-01T00:00:00Z" @default.
- Q66034092 P6099 Q42824827 @default.
- Q66034092 P6153 Q1130172 @default.
- Q66034092 P8363 Q78089383 @default.